Abstract
G-protein-coupled receptors (GPCRs) represent the main family of cell surface receptors and are virtually expressed in all eukaryotic cells. Interestingly, a large number of clinically used drugs exert their pharmacological effect via a GPCR, thus it seems crucial to deeply understand the biology of these receptors. The study of GPCR activation and signaling has been classically performed by physiological, biochemical and pharmacological approaches using radioactivity-based tools. However, apart from the potential hazards of radioisotope handling and environmental burden, these approaches have some technical limitations. Therefore, the development of fluorescence-based techniques in general and fluorescence and bioluminescence resonance energy transfer (FRET and BRET) in particular have revolutionized the way to study GPCR functioning both in vitro and in vivo. Indeed, these techniques allow the characterization and visualization of all the individual GPCR signaling steps (i.e. ligand binding, receptor activation, G-protein coupling, G-protein activation, GPCR desensitization) with high temporal and spatial resolution. Here, we review the use and impact of fluorescent-based methodologies on the deciphering of GPCR biology.
Keywords: BRET, FRET, G protein-coupled receptor, ligand-receptor interaction, protein-protein interaction.
Current Pharmaceutical Biotechnology
Title:Deciphering G Protein-Coupled Receptor Biology with Fluorescence-based Methods
Volume: 15 Issue: 10
Author(s): Francisco Ciruela, Antoni Vallano, Maria L. Cuffi, Lourdes Carbonell, Silvia Sanchez, Josep M. Arnau, Carla Tasca, Victor Fernandez-Duenas and Maricel Gomez-Soler
Affiliation:
Keywords: BRET, FRET, G protein-coupled receptor, ligand-receptor interaction, protein-protein interaction.
Abstract: G-protein-coupled receptors (GPCRs) represent the main family of cell surface receptors and are virtually expressed in all eukaryotic cells. Interestingly, a large number of clinically used drugs exert their pharmacological effect via a GPCR, thus it seems crucial to deeply understand the biology of these receptors. The study of GPCR activation and signaling has been classically performed by physiological, biochemical and pharmacological approaches using radioactivity-based tools. However, apart from the potential hazards of radioisotope handling and environmental burden, these approaches have some technical limitations. Therefore, the development of fluorescence-based techniques in general and fluorescence and bioluminescence resonance energy transfer (FRET and BRET) in particular have revolutionized the way to study GPCR functioning both in vitro and in vivo. Indeed, these techniques allow the characterization and visualization of all the individual GPCR signaling steps (i.e. ligand binding, receptor activation, G-protein coupling, G-protein activation, GPCR desensitization) with high temporal and spatial resolution. Here, we review the use and impact of fluorescent-based methodologies on the deciphering of GPCR biology.
Export Options
About this article
Cite this article as:
Ciruela Francisco, Vallano Antoni, Cuffi L. Maria, Carbonell Lourdes, Sanchez Silvia, Arnau M. Josep, Tasca Carla, Fernandez-Duenas Victor and Gomez-Soler Maricel, Deciphering G Protein-Coupled Receptor Biology with Fluorescence-based Methods, Current Pharmaceutical Biotechnology 2014; 15 (10) . https://dx.doi.org/10.2174/1389201015666140909125119
DOI https://dx.doi.org/10.2174/1389201015666140909125119 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Current Highlights About the Safety of Inorganic Nanomaterials in Healthcare
Current Medicinal Chemistry An Up-date of Olive Oil Phenols in Inflammation and Cancer: Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry Strategies to Reduce Oxidative Stress in Glaucoma Patients
Current Neuropharmacology Exosomal miR-214-5p Released from Glioblastoma Cells Modulates Inflammatory Response of Microglia after Lipopolysaccharide Stimulation through Targeting CXCR5
CNS & Neurological Disorders - Drug Targets Cerebrospinal Fluid Proteins in the Diagnosis of Alzheimers Disease
Recent Patents on CNS Drug Discovery (Discontinued) Modulating Interleukins and their Receptors Interactions with Small Chemicals Using In Silico Approach for Asthma
Current Topics in Medicinal Chemistry Cross-Talk Between TGF-β and NADPH Oxidases During Liver Fibrosis and Hepatocarcinogenesis
Current Pharmaceutical Design Anti-Inflammatory Responses of Resveratrol
Inflammation & Allergy - Drug Targets (Discontinued) Oxaliplatin-Induced Lung Toxicity. Case Report and Review of the Literature
Current Drug Safety NADPH Oxidase as a Target for Modulation of Radiation Response; Implications to Carcinogenesis and Radiotherapy
Current Molecular Pharmacology Regulation of Expression and Function of IDO in Human Dendritic Cells
Current Medicinal Chemistry Bioinformatics and Drug Discovery
Current Topics in Medicinal Chemistry Viscosupplementation with Intra-Articular Hyaluronic Acid for Treatment of Osteoarthritis in the Elderly
Current Pharmaceutical Design Cytokine-Induced Inflammatory Liver Injuries
Current Molecular Medicine Preclinical and Clinical Studies of Novel Breast Cancer Drugs Targeting Molecules Involved in Protein Kinase C Signaling, the Putative Metastasis-Suppressor Gene Cap43 and the Y-box Binding Protein-1
Current Medicinal Chemistry Olfactory Receptor Multigene Family in Vertebrates: From the Viewpoint of Evolutionary Genomics
Current Genomics Therapeutic Enhancement of IL-2 Through Molecular Design
Current Pharmaceutical Design Therapeutic Angiogenesis for Limb Ischemia Using Angiogenic Growth Factors and Carriers
Current Tissue Engineering (Discontinued) Preface (Hot Topic: Regulatory Peptides Executive Editor: Dr. Nese Tuncel)
Current Pharmaceutical Design Arbidol: A Broad-Spectrum Antiviral Compound that Blocks Viral Fusion
Current Medicinal Chemistry